Pharmaceutical

Rhenium (186Re) obisbemeda by Plus Therapeutics for Hea...

Oct 29, 2023

Rhenium (186Re) obisbemeda is under clinical development by Plus Therapeutics an...

Rhenium (186Re) obisbemeda by Plus Therapeutics for Tri...

Oct 29, 2023

Rhenium (186Re) obisbemeda is under clinical development by Plus Therapeutics an...

PBCAR-19B by Precision Biosciences for Mantle Cell Lymp...

Oct 29, 2023

PBCAR-19B is under clinical development by Precision Biosciences and currently i...

DF-003 by Drug Farm for Chronic Kidney Disease (Chronic...

Oct 29, 2023

DF-003 is under clinical development by Drug Farm and currently in Phase I for C...

(CST-2032 + nadolol) by CuraSen Therapeutics for Dement...

Oct 29, 2023

(CST-2032 + nadolol) is under clinical development by CuraSen Therapeutics and c...

An Ask Me Anything with STAT’s Nicholas St. Fleur

An Ask Me Anything with STAT’s Nicholas St. Fleur

Oct 28, 2023

Read an Ask Me Anything with STAT’s Nicholas St. Fleur: his favorite parts of th...

STAT+: Biden administration proposes fixes to No Surprises Act’s dispute resolution process

STAT+: Biden administration proposes fixes to No Surpri...

Oct 28, 2023

The proposal aims to increase early communication between insurers and providers...

Senate committee plans Nov. 8 vote on wide-ranging health care package

Senate committee plans Nov. 8 vote on wide-ranging heal...

Oct 28, 2023

The Senate Finance Committee plans to move ahead with a wide-ranging health care...

Paying for Covid pills will soon shift to insurers

Paying for Covid pills will soon shift to insurers

Oct 28, 2023

The Biden administration is slowly shifting millions of Covid-19 treatments to p...

STAT+: FDA has some safety concerns about CRISPR-based sickle cell treatment, documents show

STAT+: FDA has some safety concerns about CRISPR-based ...

Oct 28, 2023

The FDA said it has some safety concerns about an experimental CRISPR-based trea...

STAT+: Why Sanofi got shellacked

STAT+: Why Sanofi got shellacked

Oct 28, 2023

Sanofi, the Paris-based drug giant, announced that it would spin out its $5 bill...

STAT+: Up and Down the Ladder: The latest comings and goings

STAT+: Up and Down the Ladder: The latest comings and g...

Oct 28, 2023

From new hires to departures, transfers and promotions, here are the latest comi...

Regeneron gene therapy improves hearing in child

Regeneron gene therapy improves hearing in child

Oct 28, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer

STAT+: Pharmalittle: Sanofi plans to spin off its consu...

Oct 28, 2023

The European Medicines Agency disclosed that its safety panel did not find a cau...

STAT+: In major test for prime editing, scientists successfully correct mutations in monkeys

STAT+: In major test for prime editing, scientists succ...

Oct 28, 2023

Prime Medicine says its refinement of CRISPR passed the major test of correcting...

STAT+: ARPA-H head Renee Wegrzyn on the agency’s new Cambridge hub and plans for cancer research

STAT+: ARPA-H head Renee Wegrzyn on the agency’s new Ca...

Oct 28, 2023

"We look for the areas that we see our asymmetrical investment can really advanc...